Related Articles
CD57 ratio as a convenient and useful immunological and prognostic parameter for stage IV carcinoma
Adoptive immunotherapy using autologous lymphocytes sensitized with HLA class I-matched allogeneic tumor cells
The increase of CD57+ T cells in the peripheral blood and their impaired immune functions in patients with advanced gastric cancer
Principal component analysis of early immune cell dynamics during pembrolizumab treatment of advanced urothelial carcinoma
The pathogenic response of cytotoxic T‑lymphocytes, a common therapeutic target for cancer, has a direct impact on treatment outcomes (Review)